Novel quinazolinamide derivatives of the formula (I), in which R
1
-R
4
and X have the meanings indicated in Claim
1
, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
式(I)中的新型
喹唑啉酰胺衍
生物,其中R1-R4和X具有权利要求书中指示的含义,是
HSP90
抑制剂,可用于制备用于治疗
HSP90起作用的疾病的药物。